Investor's Business Daily on MSN
Apellis Pharmaceuticals shows rising relative price performance; still shy of key benchmark
Apellis Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...
Stocks edged lower on Wall Street as trading for 2025 nudges closer to the finish line. The S&P 500 fell 0.1% Tuesday. The ...
Stocks on Wall Street are largely unchanged as trading for 2025 nudges closer to the finish line. The Dow dipped 0.3% while ...
By some measures, China’s economy is looking resilient, with strong exports and breakthroughs in artificial intelligence and ...
Alphabet is the most complete end-to-end AI company on the planet, and the advantages of its vertical integration and its ...
10hon MSN
US tariff rates will end 2025 above 15%. Experts don't expect these rates to come down much in 2026.
Analysts looking forward to what is in store on the tariff front in 2026 see limited deescalation as likely next year, with ...
Just like past tech booms, the latest frenzy has produced a group of billionaires — at least on paper — from smaller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results